{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T13:24:22Z","timestamp":1744377862326},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s10072-008-0903-8","type":"journal-article","created":{"date-parts":[[2008,6,10]],"date-time":"2008-06-10T08:31:26Z","timestamp":1213086686000},"page":"127-130","source":"Crossref","is-referenced-by-count":6,"title":["Peripheral mechanism of action of antimigraine prophylactic drugs"],"prefix":"10.1007","volume":"29","author":[{"given":"Fabio","family":"Frediani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Villani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Casucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,11]]},"reference":[{"key":"903_CR1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.41.2_Part_1.182","volume":"41","author":"M.A. Moskowitz","year":"1991","unstructured":"Moskowitz MA (1991) The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 41:182\u2013186","journal-title":"Neurology"},{"key":"903_CR2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1096-9861(19981012)400:1<125::AID-CNE9>3.0.CO;2-B","volume":"400","author":"A. Malick","year":"1998","unstructured":"Malick A, Burstein R (1998) Cells of origin of the trigeminohypothalamic tract in the rat. J Comp Neurol 400:125\u2013144","journal-title":"J Comp Neurol"},{"key":"903_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ana.410160202","volume":"16","author":"M.A. Moskowitz","year":"1984","unstructured":"Moskowitz MA (1984) The neurobiology of vascular head pain. Ann Neurol 16:157\u2013168","journal-title":"Ann Neurol"},{"key":"903_CR4","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1523\/JNEUROSCI.07-12-04129.1987","volume":"7","author":"S. Markovitz","year":"1987","unstructured":"Markovitz S, Saito K, Moskowitz MA (1987) Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 7:4129\u20134136","journal-title":"J Neurosci"},{"key":"903_CR5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","volume":"28","author":"P.J. Goadsby","year":"1990","unstructured":"Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183\u2013187","journal-title":"Ann Neurol"},{"key":"903_CR6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3959(00)00478-4","volume":"89","author":"R. Burstein","year":"2001","unstructured":"Burstein R (2001) Deconstructing migraine headache into peripheral and central sensitization. Pain 89:107\u2013110","journal-title":"Pain"},{"key":"903_CR7","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/0028-3908(91)90165-8","volume":"30","author":"M.G. Buzzi","year":"1991","unstructured":"Buzzi MG, Carter WB, Shimizu T et al (1991) Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 30:1193\u20131200","journal-title":"Neuropharmacology"},{"key":"903_CR8","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1073\/pnas.0306147101","volume":"101","author":"D. Levy","year":"2004","unstructured":"Levy D, Jakubowski M, Burstein R (2004) Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B\/1D receptor agonists. Proc Natl Acad Sci U S A 101:4274\u20134279","journal-title":"Proc Natl Acad Sci U S A"},{"key":"903_CR9","first-page":"109","volume":"43","author":"S. Moncada","year":"1991","unstructured":"Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109\u2013142","journal-title":"Pharmacol Rev"},{"key":"903_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1468-2982.1988.0801001.x","volume":"8","author":"Headache Classification Committee of the International Headache Society","year":"1988","unstructured":"Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8:1\u201396","journal-title":"Cephalalgia"},{"key":"903_CR11","first-page":"17","volume":"38","author":"H.K. Iversen","year":"1989","unstructured":"Iversen HK, Olesen J, Tfelt-Hansen P (1989) Intravenous nitroglycerin as an experimental headache model. Basic characteristics. Pain 38:17\u201324","journal-title":"Basic characteristics. Pain"},{"key":"903_CR12","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/00001756-199308000-00008","volume":"4","author":"J. Olesen","year":"1993","unstructured":"Olesen J, Iversen HK, Thomsen LL (1993) Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport 4:1027\u20131030","journal-title":"Neuroreport"},{"key":"903_CR13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-6147(94)90075-2","volume":"15","author":"J. Olesen","year":"1994","unstructured":"Olesen J, Thomsen LL, Iversen HK (1994) Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 15:149\u2013153","journal-title":"Trends Pharmacol Sci"},{"key":"903_CR14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1468-2982.1996.1606412.x","volume":"16","author":"H.K. Iversen","year":"1996","unstructured":"Iversen HK, Olesen J (1996) Headache induced by a nitric oxide donor responds to sumatriptan-a human model for development of migraine drugs. Cephalalgia 16:412\u2013418","journal-title":"Cephalalgia"},{"key":"903_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(99)01985-X","volume":"847","author":"S.J. Read","year":"1999","unstructured":"Read SJ, Manning P, McNeil CJ et al. (1999) Effects of sumatriptan on nitric oxide and superoxide balance during glyceryl trinitrate infusion in the rat. Implications for anti-migraine mechanism. Brain Res 847:1\u20138","journal-title":"Brain Res"},{"key":"903_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-510X(00)00357-9","volume":"178","author":"R.P. Withe","year":"2000","unstructured":"Withe RP, Deane C, Hindley C et al (2000) The effect of the nitric oxide donor glyceryl trinitrate on global and regional cerebral blood flow in man. J Neurol Sci 178:23\u201328","journal-title":"J Neurol Sci"},{"key":"903_CR17","first-page":"648","volume":"48","author":"J. Olesen","year":"2000","unstructured":"Olesen J, Jansen-Olesen I (2000) Nitric oxide mechanisms in migraine. Pathol Biol 48:648\u2013657","journal-title":"Pathol Biol"},{"key":"903_CR18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-6147(94)90075-2","volume":"15","author":"J. Olesen","year":"1994","unstructured":"Olesen J, Thomsen LL, Iversen HK (1994) Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 15:149\u2013153","journal-title":"Trends Pharmacol Sci"},{"key":"903_CR19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410330109","volume":"33","author":"P.J. Goadsby","year":"1993","unstructured":"Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33:48\u201356","journal-title":"Ann Neurol"},{"key":"903_CR20","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","volume":"291","author":"J.L. Brandes","year":"2004","unstructured":"Brandes JL, Saper JR, Diamond M et al (2004) Topiramate for migraine prevention: a randomized controlled trial. JAMA 291:965\u2013973","journal-title":"JAMA"},{"key":"903_CR21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00415-004-0464-6","volume":"251","author":"H.C. Diener","year":"2004","unstructured":"Diener HC, Tfelt-Hansen P, Dahlof C et al (2004) Topiramate in migraine prophylaxis: results from a placebo controlled trial with propranolol as an active control. J Neurol 251:943\u2013950","journal-title":"J Neurol"},{"key":"903_CR22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1468-2982.2004.00767.x","volume":"24","author":"R.J. Storer","year":"2004","unstructured":"Storer RJ, Goadsby PJ (2004) Topiramate inhibits trigeminovascular neurons in the cat. Cephalalgia 24:1049\u20131056","journal-title":"Cephalalgia"},{"key":"903_CR23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.bjp.0706290","volume":"146","author":"S. Akerman","year":"2005","unstructured":"Akerman S, Goadsby PJ (2005) Topiramate inhibits trigeminovascular activation: an intravital microscopic study. Br J Pharmacol 146:7\u201314","journal-title":"Br J Pharmacol"},{"key":"903_CR24","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/01.RES.70.6.1313","volume":"70","author":"E.P. Wei","year":"1992","unstructured":"Wei EP, Moskowitz MA, Boccalini P et al (1992) Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilatation in feline cerebral arterioles. Circ Res 70:1313\u20131319","journal-title":"Circ Res"},{"key":"903_CR25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/sj.bjp.0704842","volume":"137","author":"S. Akerman","year":"2002","unstructured":"Akerman S, Williamson DJ, Kaube H et al (2002) Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol 137:62\u201368","journal-title":"Br J Pharmacol"},{"key":"903_CR26","unstructured":"Ramadan NM, Silberstein SD, Freitag FG et al (2000) Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for the prevention of migraine. Available at http:\/\/www.aan.com\/professionals\/prac-tice\/pdfs\/gl0090.pdf"},{"key":"903_CR27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pharmthera.2005.04.010","volume":"112","author":"N.M. Ramadan","year":"2006","unstructured":"Ramadan NM, Buchanan TM (2006) New and future migraine therapy. Pharmacol Ther 112:199\u2013212","journal-title":"Pharmacol Ther"},{"key":"903_CR28","first-page":"381","volume":"40","author":"J.L. Montastruc","year":"1992","unstructured":"Montastruc JL, Senard JM (1992) Calcium channel blockers and prevention of migraine. Pathol Biol 40:381\u2013388","journal-title":"Pathol Biol"},{"key":"903_CR29","doi-asserted-by":"crossref","unstructured":"Louis P (1981) A double-blind, placebo controlled prophylactic study of flunarizine in migraine. Headache 235-239","DOI":"10.1111\/j.1526-4610.1981.hed2106235.x"},{"key":"903_CR30","doi-asserted-by":"crossref","unstructured":"Peroutka SJ (1990) The pharmacology of current antimigraine drugs. Headache 5\u201311","DOI":"10.1111\/j.1526-4610.1990.hed30s1005.x"},{"key":"903_CR31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(97)10103-0","volume":"329","author":"K. Ayajiki","year":"1997","unstructured":"Ayajiki K, Okamura T, Toda N (1997) Flunarizine an antimigraine agent impairs nitroxidergic nerve function in cerebral arteries. Eur J Pharmacol 329:49\u201353","journal-title":"Eur J Pharmacol"},{"key":"903_CR32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0304-3940(93)90621-Q","volume":"158","author":"J.J. Geer","year":"1993","unstructured":"Geer JJ, Dooley DJ, Adams ME (1993) K(+)-stimulated Ca2+ flux into rat neocortical mini-slices is blocked by omega-Aga-IVA and the dual Na+\/Ca2+ channel blockers lidoflazide and flunarizine. Neurosci Lett 158:97\u2013100","journal-title":"Neurosci Lett"},{"key":"903_CR33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1468-2982.2002.00386.x","volume":"22","author":"S.D. Silberstein","year":"2002","unstructured":"Silberstein SD, Goadsby PJ (2002) Migraine: preventive treatment. Cephalalgia 22:491\u2013512","journal-title":"Cephalalgia"},{"key":"903_CR34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/jn.1944.7.6.359","volume":"7","author":"A.A. Le\u00e3o","year":"1944","unstructured":"Le\u00e3o AA (1944) Spreading depression of activity in cerebral cortex. J Neurophysiol 7:359\u2013390","journal-title":"J Neurophysiol"},{"key":"903_CR35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1152\/jn.1944.7.6.391","volume":"7","author":"A.A.P. Le\u00e3o","year":"1944","unstructured":"Le\u00e3o AAP (1944) Pial circulation and spreading depression of activity in the cerebral cortex. J Neurophysiol 7:391\u2013396","journal-title":"J Neurophysiol"},{"key":"903_CR36","first-page":"444","volume":"80","author":"K. Omote","year":"1995","unstructured":"Omote K, Iwasaki H, Kawamata M et al (1995) Effect of verapamil on spinal anesthesia with local anesthetics. Anesth Analg 80:444\u2013448","journal-title":"Anesth Analg"},{"key":"903_CR37","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/sj.bjp.0705456","volume":"140","author":"S. Akerman","year":"2003","unstructured":"Akerman S, Williamson DJ, Goadsby PJ (2003) Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism. Br J Pharmacol 140:558\u2013566","journal-title":"Br J Pharmacol"},{"key":"903_CR38","first-page":"335","volume":"19","author":"H.C. Diener","year":"2000","unstructured":"Diener HC, Brune K, Gerber WD et al (2000) Therapy of migraine attack and migraine prophylaxis. Nervenheilkunde 19:335\u2013345","journal-title":"Nervenheilkunde"},{"issue":"[Suppl5]","key":"903_CR39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/03331024860060S501","volume":"6","author":"B. Ablad","year":"1986","unstructured":"Ablad B, Dahl\u00f6f C (1986) Migraine and beta-blockade: modulation of sympathetic neurotransmission. Cephalalgia 6[Suppl 5]:7\u201313","journal-title":"Cephalalgia"},{"key":"903_CR40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5414\/CPP39383","volume":"39","author":"T.J. Cleophus","year":"2001","unstructured":"Cleophus TJ, Zwinderman AH (2001) Beta-blockers and heart failure: meta-analysis of mortality trials. Int J Clin F Ther 39:383\u2013387","journal-title":"Int J Clin F Ther"},{"key":"903_CR41","first-page":"589","volume":"43","author":"R.G. Kaniecki","year":"2003","unstructured":"Kaniecki RG (2003) Migraine prevention with carvedilol: a prospective, open-label trial. Headache 43:589","journal-title":"Headache"},{"key":"903_CR42","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","volume":"75","author":"J. Jankovic","year":"2004","unstructured":"Jankovic J (2004) Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry 75:951\u2013957","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"903_CR43","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1526-4610.2000.00066.x","volume":"40","author":"S. Silberstein","year":"2000","unstructured":"Silberstein S et al (2000) Botulinum toxin type A as a migraine preventive treatment: for the Botox Migraine Clinical Research Group. Headache 40:445\u2013450","journal-title":"Headache"},{"key":"903_CR44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","volume":"44","author":"P.L. Durham","year":"2004","unstructured":"Durham PL, Cady R, Cady R (2004) Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 44:35\u201342","journal-title":"Headache"},{"key":"903_CR45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bmj.322.7277.19","volume":"322","author":"H. Schrader","year":"2001","unstructured":"Schrader H, Stovner LJ, Helde G et al (2001) Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomized, placebo-controlled, cross-over study. BMJ 322:19\u201322","journal-title":"BMJ"},{"key":"903_CR46","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1526-4610.2007.00824.x","volume":"47","author":"F.L. Medeiros","year":"2007","unstructured":"Medeiros FL, Medeiros PL, Valen\u00e7a MM, Dodick D (2007) Simvastatin for migraine prevention. Headache 47:855\u2013856","journal-title":"Headache"},{"key":"903_CR47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(89)90719-X","volume":"165","author":"M.G. Buzzi","year":"1989","unstructured":"Buzzi MG, Sakas DE, Moskowitz MA (1989) Indomethacin and acetylsalicyclic acid block neurogenic plasma proteins extravasion in rat dura mater. Eur J Pharmacol 165:251\u2013258","journal-title":"Eur J Pharmacol"},{"key":"903_CR48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-6147(94)90075-2","volume":"15","author":"J. Olesen","year":"1994","unstructured":"Olesen J, Thomsen LL, Iversen H (1994) Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 15:149\u2013153","journal-title":"Trends Pharmacol Sci"},{"key":"903_CR49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1468-2982.2001.00168.x","volume":"21","author":"H.C. Diener","year":"2001","unstructured":"Diener HC, Hartung E, Chrubasik J et al (2001) A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia 21:120\u2013128","journal-title":"Cephalalgia"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-008-0903-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-008-0903-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-008-0903-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:11:35Z","timestamp":1559106695000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-008-0903-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":49,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["903"],"URL":"https:\/\/doi.org\/10.1007\/s10072-008-0903-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}